Ponatinib Hydrochloride(poh-NA-tih-nib HY-droh-KLOR-ide)
This page contains brief information about ponatinib hydrochloride and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
|US Brand Name(s):||Iclusig|
As of October 31, 2013, ponatinib hydrochloride is no longer available to new patients, due to concerns about whether the drug is safe and effective. Patients who are already being treated with this drug may continue their treatment, depending on their doctor's advice. To learn more, see Ponatinib Hydrochloride Withdrawn from U.S. Markets.
Ponatinib hydrochloride was originally approved to treat:
It is used in patients who cannot be treated with or have not gotten better with other tyrosine kinase inhibitors.
Ponatinib hydrochloride continues to be studied in the treatment of leukemia and other conditions.More About Ponatinib Hydrochloride
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
MedlinePlus Information on Ponatinib Hydrochloride - A lay language summary of important information about this drug that may include the following:
- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.
Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.Research Results
Clinical Trial Results: New Drug Shows Promise Against Drug-Resistant Leukemias - Important clinical trial results for this drug, background information, and how the trial was done.Clinical Trials Accepting Patients
Find Clinical Trials for Ponatinib Hydrochloride - Check for trials from NCI's list of cancer clinical trials now accepting patients.
Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.